NYSE · CIK 0000910329
MED MEDIFAST INC
Insider trading from SEC Form 4. Last filing 13 d ago. Close $11.61 on Oct 9, 2026, +23% from the 52-week low and -17% from the high.
Last 90 days
Net insider value
-$226k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$226k by 1 insider
Insiders on file
9
with a Form 4 at this company
Price and insider trades, last year
MEDOct 9, 2026 · close 11.61
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at MEDIFAST INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 13Weak | Daniel R Chard Chairman & CEO sell | $226k 19,089 shares | -13% | - | |
| 63Notable | Daniel R Chard Chairman & CEO buy | $179k 17,678 shares | - | +5% from low-34% from high | |
| 38Weak | Daniel R Chard Chairman & CEO buy | $5,003 381 shares | +0% | +9% from low-40% from high |
Transactions
The last 30 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | Daniel R Chard Chairman & CEO | SOpen-market sale Common Stockindirect: The Dan and Allyson Family Irrevocable Trust10b5-1 | -9,545 | $11.98 | $114k | 140,153 | 13 d ago |
| Sep 29, 2026 | Daniel R Chard Chairman & CEO | SOpen-market sale Common Stockindirect: The Dan and Allyson Family Irrevocable Trust10b5-1 | -9,544 | $11.73 | $112k | 130,609 | 13 d ago |
| Mar 13, 2026 | James P. Maloney Chief Financial Officer | FTax withholding Common Stock | -918 | $9.62 | $8,831 | 41,381 | Mar 27, 2026 |
| Mar 13, 2026 | Jonathan Barrett MacKenzie VP, Finance & CAO | FTax withholding Common Stock | -198 | $9.62 | $1,905 | 10,940 | Mar 27, 2026 |
| Mar 13, 2026 | Daniel R Chard Chairman & CEO | FTax withholding Common Stock | -7,075 | $9.62 | $68k | 169,171 | Mar 27, 2026 |
| Mar 17, 2026 | Daniel R Chard Chairman & CEO | FTax withholding Common Stock | -2,638 | $10.05 | $27k | 166,533 | Mar 27, 2026 |
| Mar 17, 2026 | James P. Maloney Chief Financial Officer | FTax withholding Common Stock | -482 | $10.05 | $4,844 | 40,899 | Mar 27, 2026 |
| Mar 17, 2026 | Jonathan Barrett MacKenzie VP, Finance & CAO | FTax withholding Common Stock | -70 | $10.05 | $704 | 10,870 | Mar 27, 2026 |
| Mar 25, 2026 | Jonathan Barrett MacKenzie VP, Finance & CAO | FTax withholding Common Stock | -862 | $9.59 | $8,267 | 10,008 | Mar 27, 2026 |
| Mar 20, 2026 | Daniel R Chard Chairman & CEO | POpen-market purchase Common Stockindirect: Dan and Allyson as Joint Tenants | +17,678 | $10.11 | $179k | 17,678 | Mar 27, 2026 |
| Mar 25, 2026 | James P. Maloney Chief Financial Officer | FTax withholding Common Stock | -3,224 | $9.59 | $31k | 37,675 | Mar 27, 2026 |
| Mar 25, 2026 | James P. Maloney Chief Financial Officer | AGrant or award Common Stock | +34,344 | $0.00 | $0 | 72,019 | Mar 27, 2026 |
| Mar 25, 2026 | Jonathan Barrett MacKenzie VP, Finance & CAO | AGrant or award Common Stock | +10,830 | $0.00 | $0 | 20,838 | Mar 27, 2026 |
| Mar 25, 2026 | Daniel R Chard Chairman & CEO | FTax withholding Common Stock | -20,095 | $9.59 | $193k | 146,438 | Mar 27, 2026 |
| Mar 25, 2026 | James P. Maloney Chief Financial Officer | AGrant or award Common Stock | +1,014 | $0.00 | $0 | 73,033 | Mar 27, 2026 |
| Mar 25, 2026 | Daniel R Chard Chairman & CEO | AGrant or award Common Stock | +36,968 | $0.00 | $0 | 183,406 | Mar 27, 2026 |
| Mar 25, 2026 | Daniel R Chard Chairman & CEO | AGrant or award Common Stock | +4,827 | $0.00 | $0 | 188,233 | Mar 27, 2026 |
| Jun 25, 2025 | Jeffrey J Brown director | AGrant or award Common Stock | +11,168 | $0.00 | $0 | 29,128 | Jun 26, 2025 |
| Jun 25, 2025 | Ming Xian director | AGrant or award Restricted Stock Units (cash settled)derivative | +11,168 | $0.00 | $0 | 26,130 | Jun 26, 2025 |
| Jun 25, 2025 | Scott Schlackman director | AGrant or award Common Stock | +11,168 | $0.00 | $0 | 25,549 | Jun 26, 2025 |
| Jun 25, 2025 | Andrea B Thomas director | AGrant or award Common Stock | +11,168 | $0.00 | $0 | 24,017 | Jun 26, 2025 |
| Jun 25, 2025 | Michael A. Hoer director | AGrant or award Common Stock | +11,168 | $0.00 | $0 | 26,139 | Jun 26, 2025 |
| Jun 25, 2025 | Elizabeth A. Geary director | AGrant or award Common Stock | +11,168 | $0.00 | $0 | 19,545 | Jun 26, 2025 |
| Jun 25, 2025 | Jeffrey J Brown director | AGrant or award Common Stock | +9,449 | $13.39 | $127k | 38,578 | Jun 26, 2025 |
| Jun 25, 2025 | Ming Xian director | AGrant or award Restricted Stock Units (cash settled)derivative | +6,013 | $13.39 | $81k | 32,143 | Jun 26, 2025 |
| Jun 13, 2025 | Daniel R Chard Chairman & CEO | POpen-market purchase Common Stockindirect: The Dan and Allyson Family Irrevocable Trust | +381 | $13.13 | $5,003 | 149,698 | Jun 17, 2025 |
| Mar 25, 2025 | Daniel R Chard Chairman & CEO | AGrant or award Common Stock | +124,953 | $0.00 | $0 | 176,246 | Mar 27, 2025 |
| Mar 13, 2025 | Daniel R Chard Chairman & CEO | FTax withholding Common Stock | -5,001 | $13.87 | $69k | 54,101 | Mar 18, 2025 |
| Mar 16, 2025 | Daniel R Chard Chairman & CEO | FTax withholding Common Stock | -944 | $13.94 | $13k | 53,157 | Mar 18, 2025 |
| Mar 17, 2025 | Daniel R Chard Chairman & CEO | FTax withholding Common Stock | -1,864 | $14.35 | $27k | 51,293 | Mar 18, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Jeffrey J Browndirector
- Daniel R ChardChairman & CEO
- Elizabeth A. Gearydirector
- Michael A. Hoerdirector
- Jonathan Barrett MacKenzieVP, Finance & CAO
- James P. MaloneyChief Financial Officer
- Scott Schlackmandirector
- Andrea B Thomasdirector
- Ming Xiandirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.